Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Biosimilars: SOP for Equipment Maintenance Log Review – V 2.0

Posted on By


Biosimilars: SOP for Equipment Maintenance Log Review – V 2.0


Standard Operating Procedure for Equipment Maintenance Log Review in Biosimilar Manufacturing

Department Biosimilars
SOP No. SOP/BS/130/2025
Supersedes SOP/BS/130/2022
Page No. Page 1 of 11
Issue Date 04/05/2025
Effective Date 06/05/2025
Review Date 04/05/2026

1. Purpose

To define the procedure for periodic review and verification of equipment maintenance logs to ensure compliance with preventive maintenance (PM) schedules, traceability, and GMP readiness in biosimilar manufacturing facilities.

2. Scope

This SOP applies to all production and QC equipment including bioreactors, incubators, autoclaves, centrifuges, chromatography skids, and HVAC systems installed within biosimilar manufacturing units.

3. Responsibilities

  • Engineering Department: Maintain equipment logs and perform maintenance activities.
  • User Departments (Production/QC): Inform engineering of maintenance needs and verify completion status.
  • QA: Periodically review maintenance logs and ensure corrective actions are closed before batch release.

4. Accountability

The Head of Engineering is accountable for implementing the preventive maintenance schedule and ensuring that all equipment maintenance is documented and reviewed according to regulatory requirements.

5. Procedure

5.1 Maintenance Log Format and Structure

  1. Each equipment must have a dedicated logbook or system-generated maintenance file.
  2. Entries must include:
    • Equipment ID and Location
    • Date of Activity
    • Type of Maintenance (Routine, Breakdown, Calibration)
    • Performed By and Checked By

5.2 Review Frequency

  1. QA shall review equipment maintenance logs on a:
    • Monthly Basis – Critical Equipment
    • Quarterly Basis – Supportive Equipment

5.3 Review Parameters

  1. QA shall verify:
    • Timely completion of preventive maintenance
    • Adherence to equipment calibration schedule
    • Closure of breakdowns and deviation reports
    • Legibility and completeness of entries
  2. Record remarks in Annexure-1: Maintenance Review Checklist.

5.4 Deviation and Delay Handling

  1. Any missed maintenance or overdue activity must be recorded in Annexure-2: Maintenance Deviation Log.
  2. Engineering shall initiate a Corrective and Preventive Action (CAPA) for repeated delays.

5.5 Archival and Record Retention

  1. Completed maintenance logs must be archived in the Engineering document control room for 5 years.
  2. Electronic records must be backed up as per SOP/BS/122/2025 on control system backup.

6. Abbreviations

  • PM: Preventive Maintenance
  • CAPA: Corrective and Preventive Action
  • QA: Quality Assurance

7. Documents

  1. Maintenance Review Checklist – Annexure-1
  2. Maintenance Deviation Log – Annexure-2

8. References

  • WHO TRS 986 Annex 2 – GMP for Biologics
  • EU GMP Chapter 4 – Documentation
  • ISPE Baseline Guide: Commissioning and Qualification

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Maintenance Review Checklist

Equipment ID Reviewed Date Reviewed By Remarks Status
BR-100L 04/05/2025 Sunita Reddy PM done on time Compliant

Annexure-2: Maintenance Deviation Log

Deviation No. Date Equipment ID Description CAPA Reference
DEV-MNT-006 02/05/2025 CHSKID-02 PM delayed by 5 days CAPA-0125

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
04/05/2025 2.0 Added deviation log and electronic record reference Compliance alignment
See also  Biosimilars: SOP for Media Hold Time Validation in Bioreactor Operations - V 2.0
Biosimilars V 2.0 Tags:biosimilar manufacturing SOP, biosimilar process validation SOP, biosimilar quality control procedure, cell line development SOP biosimilars, chromatography SOP biosimilars, cleaning validation SOP for biosimilar equipment, cleanroom SOP for biologics manufacturing, deviation handling SOP in bioprocess, downstream processing SOP, environmental monitoring SOP biosimilars, GMP SOP for biosimilars, host cell protein removal SOP, inline UV monitoring SOP biosimilars, media preparation SOP for biosimilars, protein purification SOP, purification skid calibration SOP, SOP for bioreactor inoculation biosimilars, SOP for biosimilar cell banking, SOP for cell culture in biosimilar production, SOP for chromatography column packing, SOP for ELISA-based clone screening, SOP for endotoxin testing in biologics, SOP for filter sterilization in downstream processing, SOP for glycosylation analysis in biosimilars, SOP for master cell bank, SOP for protein A chromatography steps, SOP for resin qualification in biosimilar purification, SOP for viral clearance in biosimilar production, SOP for working cell bank, upstream processing SOP biosimilars

Post navigation

Previous Post: Creams: SOP for Managing Out-of-Trend (OOT) Results – V 2.0
Next Post: Aerosol: SOP for Ensuring Propellant Purity During Storage and Use – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version